Inter have signed Brazil striker Gabriel Barbosa on a five-year deal from Santos.
Gabriel has been heavily linked with a number of
European clubs, including Premier League champions Leicester City, Paris
Saint-Germain and Inter's Serie A rivals Juventus.
Manchester United and Borussia Dortmund have also
been reported to be keen on his services, but it is Inter who have won
the race for his signature.
He is the latest addition in what has been a busy
transfer window for the Milan giants, whose other signings include
wingers Joao Mario and Antonio Candreva and attacking midfielder Ever
Banega.
An official club statement read: "Gabriel Barbosa
Almeida received a bonus present today after officially signing as an
Inter player on his 20th birthday.
"As we wait to see him in action at San Siro, the
Nerazzurri club and fans give Gabigol a warm welcome to the club,
wishing him a happy birthday and a fantastic career in a Nerazzurri
shirt."
Gabriel joins Inter on his 20th birthday after what has been a rapid rise for the forward.
He scored on his Brazil debut in the 2-0 win over Panama in March and has now struck twice in four games for the national side.
Gabriel represented his country at the Copa America
Centenario and struck a brace in the final Rio 2016 group game against
Denmark as the host nation went on to win Olympic gold.
After making his Santos debut as a substitute in
Neymar's final match before departing for Barcelona in 2013, Gabriel
scored 57 times in 157 appearances in all competitions and won the
Campeonato Paulista in 2015 and 2016.
Now he moves to an Inter side that has made a poor
start to the new season under Frank de Boer despite the heavy investment
in the squad.
Inter were beaten 2-0 by Chievo in the opening game
of the campaign and followed up that defeat with a 1-1 home draw with
Palermo.
Gabriel is
currently on international duty with Brazil ahead of their World Cup
2018 qualifiers against Ecuador and Colombia and could make his debut
for Inter on September 11 when they travel to Pescara.
No comments:
Post a Comment